摘要
目的了解高龄老年患者雾化吸入类药物的使用情况,并对使用情况进行合理性分析。方法抽取我院信息系统(HIS)中2019年1-12月应用雾化吸入类药物高龄患者(≥80岁)108例作为研究对象,并根据《雾化吸入疗法合理用药专家共识》(2019年版)、治疗指南、临床诊断、循证药学证据、药品说明书及相关文献,对其进行合理性分析。结果三种药物联合应用70例,占比最高(64.82%)。不合理用药28例,其中吸入用糖皮质激素疗程过长占比最多(46.43%)。结论高龄老年患者应用雾化吸入类药物时,临床医师对雾化吸入类药物的使用存在一些误区,药师与医师之间需相互配合以规范雾化吸入类药物合理应用。
Objective To learn about the use of aerosol inhalation drugs in elderly patients,and analyze the rationality of the drug use.Methods Totally 108 elderly patients(≥80 years old)treated with aerosol inhalation drugs in our hospital from January to December 2019 were selected as the research subjects.The rationality of drug use was analyzed according to the Expert Consensus on Rational Aerosol Inhalation Therapy(2019),the treatment guideline,the clinical diagnosis,evidence-based pharmacy,drug instructions and related literatures.Results The combination of three drugs was used in 70 cases,accounting for the highest proportion(64.82%).There were 28 cases of irrational drug use,in which the proportion of inhaled corticosteroids for a long course of treatment was the highest(46.43%).Conclusion There are some misunderstandings in the use of aerosol inhalation drugs in elderly patients.Pharmacists and physicians need to cooperate with each other to standardize the rational use of aerosol inhalation drugs.
作者
丛晓飞
陈立新
李浩
CONG Xiao-fei;CHEN Li-xin;LI Hao(Department of Pharmacy,Liaoning Jinqiu Hospital,Shen-yang 110016,China)
出处
《实用药物与临床》
CAS
2021年第10期947-949,共3页
Practical Pharmacy and Clinical Remedies
作者简介
通信作者:丛晓飞。
